Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre
Woman Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chemotherapy in patients with metastatic breast cancer
To evaluate simultaneously the Overall Response Rates (ORR) of oral vinorelbine in combination with capecitabine, gemcitabine in combination with paclitaxel and gemcitabine in combination with docetax...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament
Update Il y a 4 ans
Phase II trial of oral vinorelbine in combination with capecitabine and trastuzumab as first line therapy in women with previously untreated HER2 positive metastatic breast cancer
To evaluate the Overall Response Rate (ORR) of oral vinorelbine (Navelbine Oral) in combination with capecitabine (Xeloda) and i.v. trastuzumab (Herceptin) for HER2 positive patients.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Study in infants with infantile hemangioma to compare propranolol gel to placebo. Estudio en lactantes con hemangioma infantil para comparar propranolol gel con placebo
To assess propranolol gel efficacy in terms of complete/nearly complete resolution of the Infantile Hemangioma at W12 compared to baseline. Analizar la eficacia de propranolol gel, expresada com...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Etude chez le sujet volontaire sain de l’effet de carbolevure versus placebo sur la fermentation intestinale induite par l’ingestion de lactulose
L'objectif principal de cet essai est d’évaluer l’effet de Carbolevure® sur la fermentation intestinale induite par l’ingestion de lactulose par la mesure du taux d’hydrogène expiré.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
NON-INFERIORITY STUDY OF A METRONIDAZOLE 0.75% CREAM VERSUS REFERENCE THERAPY IN THE LOCAL TREATMENT OF PAPULOPUSTULAR ROSACEA
To assess the non-inferiority of a metronidazole 0.75% cream (Rosiced) in comparison to reference therapy (Rozex) in the local treatment of papulopustular rosacea
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Evaluation of erectyle disfonction in patients suffering from testosterone deficiency, before and after tretament by Testopatch
To evaluate the effect of testosterone supplementation with Testopatch® in hypogonadal patients complaining of erectile dysfunction.
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pierre Fabre Ibérica, S.A
Update Il y a 4 ans
Estudio en fase II de vinorelbina oral como tratamiento neoadyuvante en pacientes de más de 60 años con cáncer de mama localmente avanzado
Evaluar la respuesta patológica positiva (la respuesta completa patológica -RCp- y enfermedad residual microscópica) en mama y/o axila
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Institut de Recherche Pierre Fabre
Update Il y a 4 ans
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy
The first study objective is to define the dose-response relationship of F13640 compared to a placebo with respect to analgesic efficacy and safety in patients with moderate to severe painful peripher...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Evaluation du pouvoir bactériostatique de la préparation V0079CR CETAVLON sur la flore cutanée au niveau des mains. Etude preuve de concept
Evaluer le pouvoir bactériostatique de la préparation CETAVLON sur la flore cutanée au niveau des mains par des mesures microbiologiques (dénombrement et identification).
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine in patients with metastatic breast cancer previously treated with anthracyclines
To evaluate simultaneously the response rate of the combination of oral vinorelbine with capecitabine, a sequential regimen of oral vinorelbine and capecitabine, and the combination of docetaxel and ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
Next